Supply Chain | April 17, 2026
Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
The company allocated €56 million to research and development for next-generation line solutions
The company allocated €56 million to research and development for next-generation line solutions
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
The goal is to better support drug developers as programs move from laboratory research into clinical trials
The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy
Subscribe To Our Newsletter & Stay Updated
